Marta Vila-Gonzalez
Overview
Explore the profile of Marta Vila-Gonzalez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
190
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vila-Gonzalez M, Pinte L, Fradique R, Causa E, Kool H, Rodrat M, et al.
Respir Res
. 2024 Apr;
25(1):180.
PMID: 38664797
Background: Pulmonary ionocytes have been identified in the airway epithelium as a small population of ion transporting cells expressing high levels of CFTR (cystic fibrosis transmembrane conductance regulator), the gene...
2.
Fradique R, Causa E, Delahousse C, Kotar J, Pinte L, Vallier L, et al.
R Soc Open Sci
. 2023 Aug;
10(8):230185.
PMID: 37538747
Cilia density, distribution and beating frequency are important properties of airway epithelial tissues. These parameters are critical in diagnosing primary ciliary dyskinesia and examining models, including those derived from induced...
3.
Wong H, Cullen J, Vila-Gonzalez M, Pittaway R, Desmet V, Gillian T
J Vet Diagn Invest
. 2023 Jan;
35(2):196-200.
PMID: 36600481
Hepatic ciliated foregut remnants or cysts are congenital abnormalities resulting from retention of embryonic ciliated foregut within the liver. These structures are rarely reported in the human medical literature and...
4.
Brevini T, Maes M, Webb G, John B, Fuchs C, Buescher G, et al.
Nature
. 2022 Dec;
615(7950):134-142.
PMID: 36470304
Preventing SARS-CoV-2 infection by modulating viral host receptors, such as angiotensin-converting enzyme 2 (ACE2), could represent a new chemoprophylactic approach for COVID-19 that complements vaccination. However, the mechanisms that control...
5.
Caines R, Cochrane A, Kelaini S, Vila-Gonzalez M, Yang C, Eleftheriadou M, et al.
J Cell Sci
. 2019 Jul;
132(16).
PMID: 31331967
Dysfunction of endothelial cells (ECs) and vascular smooth muscle cells (VSMCs) leads to ischaemia, the central pathology of cardiovascular disease. Stem cell technology will revolutionise regenerative medicine, but a need...
6.
Vila-Gonzalez M, Kelaini S, Magee C, Caines R, Campbell D, Eleftheriadou M, et al.
Stem Cells
. 2018 Oct;
37(2):226-239.
PMID: 30372556
The mortality rate for (cardio)-vascular disease is one of the highest in the world, so a healthy functional endothelium is of outmost importance against vascular disease. In this study, human...
7.
Kelaini S, Vila-Gonzalez M, Caines R, Campbell D, Eleftheriadou M, Tsifaki M, et al.
Stem Cells
. 2018 Mar;
36(7):1033-1044.
PMID: 29569797
The fight against vascular disease requires functional endothelial cells (ECs) which could be provided by differentiation of induced Pluripotent Stem Cells (iPS Cells) in great numbers for use in the...
8.
Quaking Is a Key Regulator of Endothelial Cell Differentiation, Neovascularization, and Angiogenesis
Cochrane A, Kelaini S, Tsifaki M, Bojdo J, Vila-Gonzalez M, Drehmer D, et al.
Stem Cells
. 2017 Feb;
35(4):952-966.
PMID: 28207177
The capability to derive endothelial cell (ECs) from induced pluripotent stem cells (iPSCs) holds huge therapeutic potential for cardiovascular disease. This study elucidates the precise role of the RNA-binding protein...